MetaADEDB 2.0 @ LMMD
cyamemazine
(SLFGIOIONGJGRT-UHFFFAOYSA-N)
Structure
SMILES
N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
Type(s)
Experimental
ATC code(s)
N05AA06
Molecular Formula:
C19H21N3S
Molecular Weight:
323.455
Log P:
4.4237
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
55.57
CAS Number(s):
3546-03-0
Synonym(s)
1.
cyamemazine
2.
10-(3-dimethylamino-2-methylpropyl)phenothiazine-2-carbonitrile
3.
cyamamazine
4.
cyamemazine monohydrochloride
5.
cyamepromazine
External Link(s)
MeSHC028457
PubChem Compound62865
BindingDB86057
ChEBI135379
CHEMBLCHEMBL2104153
DrugBankDB09000
DrugCentral746
IUPHAR/BPS Guide to PHARMACOLOGY84
KEGGdr:D07307
Therapeutic Target DatabaseD0G7NW
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal AbscessOFFSIDES
2AbscessOFFSIDES
3Accidental overdoseOFFSIDES
4AcidosisOFFSIDES
5AkinesiaOFFSIDES
6Alanine Aminotransferase IncreasedOFFSIDES
7Alcoholic IntoxicationOFFSIDES
8Altered state of consciousnessOFFSIDES
9Anal abscessOFFSIDES
10Anticholinergic SyndromeOFFSIDES
11Anticonvulsant drug level increasedOFFSIDES
12Antiphospholipid antibodies positiveOFFSIDES
13Antipsychotic drug level above therapeuticOFFSIDES
14Antiviral drug level above therapeuticOFFSIDES
15AnuriaOFFSIDES
16AnxietyOFFSIDES
17ApathyOFFSIDES
18Apparent deathOFFSIDES
19Arterial thrombosisOFFSIDES
20Aspiration PneumoniaOFFSIDES
21AtaxiaOFFSIDES
22Atrial hypertrophyOFFSIDES
23Bacterial test positiveOFFSIDES
24Biliary dilatationOFFSIDES
25Biopsy liver abnormalOFFSIDES
26Bipolar II disorderOFFSIDES
27Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
28Blood alkaline phosphatase decreasedOFFSIDES
29Blood bicarbonateOFFSIDES
30Blood cortisol increasedOFFSIDES
31Blood creatine phosphokinase increasedOFFSIDES
32Blood creatinine decreasedOFFSIDES
33Blood immunoglobulin A decreasedOFFSIDES
34Blood pH decreasedOFFSIDES
35Blood parathyroid hormone increasedOFFSIDES
36Blood sodiumOFFSIDES
37Blood uric acid decreasedOFFSIDES
38Body TemperatureOFFSIDES
39Bone fissureOFFSIDES
40Bone marrow depressionOFFSIDES
41Bone marrow toxicityOFFSIDES
42BradycardiaOFFSIDES
43Brain scan abnormalOFFSIDES
44Bronchial ObstructionOFFSIDES
45Carcinoembryonic antigen increasedOFFSIDES
46CatatoniaOFFSIDES
47Catheter related infectionOFFSIDES
48Cell DeathOFFSIDES
49Cerebral ventricle dilatationOFFSIDES
50Chemotherapeutic drug level increasedOFFSIDES
51CholangiolitisOFFSIDES
52Conduct DisorderOFFSIDES
53ConfabulationOFFSIDES
54CryingOFFSIDES
55CryptorchidismOFFSIDES
56Cytolytic hepatitisOFFSIDES
57DehydrationOFFSIDES
58Disease recurrenceOFFSIDES
59DrowningOFFSIDES
60DrowsinessOFFSIDES
61Drug abuserOFFSIDES
62Drug dispensing errorOFFSIDES
63Drug exposure during pregnancyOFFSIDES
64Drug level below therapeuticOFFSIDES
65Drug toxicityOFFSIDES
66Dysthymic DisorderOFFSIDES
67Electrocardiogram repolarisation abnormalityOFFSIDES
68Emphysematous cystitisOFFSIDES
69EpilepsyOFFSIDES
70ErysipelasOFFSIDES
71Erythrodermic psoriasisOFFSIDES
72EscharOFFSIDES
73Escherichia sepsisOFFSIDES
74Extremity necrosisOFFSIDES
75Facial NeuralgiaOFFSIDES
76Factor V deficiencyOFFSIDES
77Fatty LiverOFFSIDES
78Febrile bone marrow aplasiaOFFSIDES
79Feeding disorder neonatalOFFSIDES
80Gamma-Glutamyltransferase IncreasedOFFSIDES
81Gastrointestinal obstructionOFFSIDES
82General physical health deteriorationOFFSIDES
83Glasgow coma scaleOFFSIDES
84GranulocytosisOFFSIDES
85HaemoconcentrationOFFSIDES
86Hepatic necrosisOFFSIDES
87HepatitisOFFSIDES
88Hepatojugular refluxOFFSIDES
89HydrocephalusOFFSIDES
90HyperparathyroidismOFFSIDES
91HyperreflexiaOFFSIDES
92HypokinesiaOFFSIDES
93HypomaniaOFFSIDES
94HyporeflexiaOFFSIDES
95Inappropriate affectOFFSIDES
96Incorrect route of drug administrationOFFSIDES
97Injury asphyxiationOFFSIDES
98Intestinal ObstructionOFFSIDES
99Kidney FailureOFFSIDES
100Leukopenia neonatalOFFSIDES
101Libido disorderOFFSIDES
102Lymph nodes scan abnormalOFFSIDES
103LymphocytosisOFFSIDES
104Meconium ileusOFFSIDES
105MegacolonOFFSIDES
106Meningeal disorderOFFSIDES
107Metabolic acidosisOFFSIDES
108MicrolithiasisOFFSIDES
109MononeuritisOFFSIDES
110Mononucleosis syndromeOFFSIDES
111Motor retardationOFFSIDES
112Multiple drug overdose intentionalOFFSIDES
113Muscle Hypertonia6110016CTD
114Muscle WeaknessOFFSIDES
115Musculoskeletal chest painOFFSIDES
116MutismOFFSIDES
117Neuroleptic Malignant SyndromeOFFSIDES
118Optic NeuropathyOFFSIDES
119Oropharyngeal plaqueOFFSIDES
120OverdoseOFFSIDES
121PROTHROMBIN TIMEOFFSIDES
122Pancreatic CystOFFSIDES
123Pancreatic PseudocystOFFSIDES
124PhlebitisOFFSIDES
125Placental InsufficiencyOFFSIDES
126PolyhydramniosOFFSIDES
127PolyneuropathyOFFSIDES
128Pre-EclampsiaOFFSIDES
129Prothrombin level decreasedOFFSIDES
130Psychomotor skills impairedOFFSIDES
131RalesOFFSIDES
132RegurgitationOFFSIDES
133Renal dysplasiaOFFSIDES
134Renal tubular disorderOFFSIDES
135RhabdomyolysisOFFSIDES
136ScotomaOFFSIDES
137Secretion dischargeOFFSIDES
138Septic ShockOFFSIDES
139Sinus bradycardiaOFFSIDES
140SoliloquyOFFSIDES
141Spina BifidaOFFSIDES
142Splenic InfarctionOFFSIDES
143SubileusOFFSIDES
144Sudden deathOFFSIDES
145TalipesOFFSIDES
146Tongue spasmOFFSIDES
147Transaminases increasedOFFSIDES
148Ulnar Nerve PalsyOFFSIDES
149Urine protein, quantitativeOFFSIDES
150Urine sodium decreasedOFFSIDES
151Wrong drug administeredOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.